News & Updates

Dietary linoleic acid helps prevent death from CVD, cancer

04 Aug 2020

Higher intake of dietary linoleic acid (LA) leads to a modest reduction in the risk of mortality from all causes, cardiovascular disease (CVD), and cancer, according to a systematic review and meta-analysis of prospective cohort studies.

Dietary linoleic acid helps prevent death from CVD, cancer

04 Aug 2020

Optimal ACEi/ARB + beta-blockers key to improved outcomes in HFrEF

03 Aug 2020 by

Patients with heart failure with reduced ejection fraction (HFrEF) who achieve 100 percent guideline-recommended target dose (GRTD) for both angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs) and β-blockers have a reduced risk of all-cause mortality and heart failure hospitalization (HHF), a recent study showed.

Optimal ACEi/ARB + beta-blockers key to improved outcomes in HFrEF

03 Aug 2020

GI bleeding less frequent with ticagrelor, prasugrel vs clopidogrel

03 Aug 2020 by

In the first year following percutaneous coronary intervention for acute coronary syndrome, ticagrelor and prasugrel cuts the risk of gastrointestinal (GI) bleeding by more than 30 percent compared with clopidogrel, as shown in a large real-world study.

GI bleeding less frequent with ticagrelor, prasugrel vs clopidogrel

03 Aug 2020

Dietary fibre intake lowers risk of CVD, diabetes, cancer

02 Aug 2020

Higher consumption of dietary fibres (DF), particularly soluble (SF) and insoluble fibres (IF) from fruits, reduces the risk of several chronic diseases and mortality, suggests a study.

Dietary fibre intake lowers risk of CVD, diabetes, cancer

02 Aug 2020

Long-term ICD survival favours patients with ischaemic HF, NYHA functional class II

01 Aug 2020

Heterogenous treatment-related patterns of long-term survival with implantable cardioverter-defibrillator (ICD) therapy have been observed among patients who participated in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) over 11 years of follow-up, with the benefit most apparent for those with ischaemic heart failure (HF) and those with New York Heart Association (NYHA) functional class II symptoms at trial enrolment.

Long-term ICD survival favours patients with ischaemic HF, NYHA functional class II

01 Aug 2020

Flurpiridaz PET holds promise as new tracer for CAD detection

01 Aug 2020

Fluorine-18 flurpiridaz positron emission tomography (PET) myocardial perfusion imaging appears to be noninferior to technetium-99m–labeled single photon emission computed tomography (SPECT) for the detection of coronary artery disease (CAD), as well as the assessment of women, obese individuals, and patients undergoing pharmacological stress testing, results of a phase III trial have shown.

Flurpiridaz PET holds promise as new tracer for CAD detection

01 Aug 2020

Snoring portends subsequent stroke-related events in selected OSA patients

31 Jul 2020

Among obstructive sleep apnoea (OSA) patients with cardiovascular disease, snoring is tied to greater risks of cerebral but not cardiac events, independent of OSA severity and continuous positive airway pressure treatment, according to data from the Sleep Apnea cardiovascular Endpoints trial.

Snoring portends subsequent stroke-related events in selected OSA patients

31 Jul 2020

EMPRISE reinforces CV benefits of empagliflozin

28 Jul 2020 by

The efficacy and cardiovascular (CV) safety of the SGLT2* inhibitor empagliflozin vs DPP-4** inhibitors and GLP-1*** receptor agonists in real-world patients were demonstrated in two interim analyses of the EMPRISE⁺ study presented at ADA 2020.

EMPRISE reinforces CV benefits of empagliflozin

28 Jul 2020

Low vitamin D levels up harmful effect of VDR variants on essential hypertension risk

28 Jul 2020

Mutations of the vitamin D receptor (VDR) appear to hasten the progression of essential hypertension (EH) aetiology, particularly when suffering from hypovitaminosis D and insufficiency, reveal the results of a cross-sectional study.

Low vitamin D levels up harmful effect of VDR variants on essential hypertension risk

28 Jul 2020

COVID-19 may exacerbate risk of deep vein thrombosis

28 Jul 2020 by

Deep vein thrombosis (DVT) appears to be common in patients with the coronavirus disease 2019 (COVID-19) and is associated with worse outcomes, a new study has found.

COVID-19 may exacerbate risk of deep vein thrombosis

28 Jul 2020

News & Updates

Filter by Specialty:

Specialty:

Dietary linoleic acid helps prevent death from CVD, cancer

Dietary linoleic acid helps prevent death from CVD, cancer

Optimal ACEi/ARB + beta-blockers key to improved outcomes in HFrEF

Optimal ACEi/ARB + beta-blockers key to improved outcomes in HFrEF

GI bleeding less frequent with ticagrelor, prasugrel vs clopidogrel

GI bleeding less frequent with ticagrelor, prasugrel vs clopidogrel

Dietary fibre intake lowers risk of CVD, diabetes, cancer

Dietary fibre intake lowers risk of CVD, diabetes, cancer

Long-term ICD survival favours patients with ischaemic HF, NYHA functional class II

Long-term ICD survival favours patients with ischaemic HF, NYHA functional class II

Flurpiridaz PET holds promise as new tracer for CAD detection

Flurpiridaz PET holds promise as new tracer for CAD detection

Snoring portends subsequent stroke-related events in selected OSA patients

Snoring portends subsequent stroke-related events in selected OSA patients

EMPRISE reinforces CV benefits of empagliflozin

EMPRISE reinforces CV benefits of empagliflozin

Low vitamin D levels up harmful effect of VDR variants on essential hypertension risk

Low vitamin D levels up harmful effect of VDR variants on essential hypertension risk

COVID-19 may exacerbate risk of deep vein thrombosis

COVID-19 may exacerbate risk of deep vein thrombosis